Virbac Launches NEW Speed Reader Biomarker Range
Virbac is delighted to announce the launch of Speed Reader, a compact and intuitive laser-induced fluorescent reader that measures the concentration of biomarkers in serum and plasma, offering an efficient and affordable solution to expand in-clinic diagnostic services.
Complemented by biomarker tests for T4, Cortisol, CPSE, Progesterone and cCRP, Speed Reader is unique in that it is the ONLY in-clinic diagnostic biomarker test for CPSE, to screen dogs for Benign Prostatic Hyperplasia, of which 80% of intact male dogs over the age of 5 years old are at risk of developing (1,2).
Speed Reader provides practices with the opportunity to increase in-clinic diagnostic testing, reducing reliance on external laboratories, delivering immediate results and improving profitability. Offered with an intuitive touch screen user interface and integrated printer, Speed Reader tests can be performed in as little as 15 minutes using a simple step-by-step procedure displayed on the touch screen.
‘The Speed Reader biomarker range is a fantastic addition to Virbac’s diagnostic portfolio’ said Andrew Connolly, Head of Marketing – Companion Animals at Virbac. ‘Not only does Speed Reader offer practices improved in-clinic diagnostic testing, but having listened to customer feedback we are also offering Speed Reader with transparent, straightforward pricing and without complex commitment contracts.’
For more information on Speed Reader, or any of the other products in the Virbac diagnostic range, please speak to your Virbac Territory Manager.
Virbac is a unique, global and family run company dedicated exclusively to animal health for over 50 years. Virbac offers a wide portfolio of innovative and award-winning products that combine quality, effectiveness and convenience for veterinary surgeons, nurses and pet owners alike.
Virbac Limited, Woolpit Business Park, Windmill Avenue, Bury St Edmunds, Suffolk, IP30 9UP
1. Lowseth LA, Gerlach RF, Gillett NA, Muggenburg BA. Age-related changes in the prostate and testes of the beagle dog. Vet Pathol. 1990 Sep; 27(5):347-53.
2. Mukaratirwa S, Chitura T. Canine subclinical prostatic disease: histological prevalence and validity of digital rectal examination as a screening test. J S Afr Vet Assoc. 2007; 78:66-8.
More from Virbac Animal Health
- Virbac Offers Interactive Online Mast Cell Tumour CPD Modules
- Virbac launches NEW Equipred - the first licensed steroid tablet for horses
- Virbac Supports Orangutan Conservation Efforts
- Virbac Announces Complimentary Oncology CPD
- Virbac Launches STELFONTA a Ground-Breaking New Treatment for Canine Mast Cell Tumours MCTs